Microbiome and pancreatic ductal adenocarcinoma.


Journal

Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 31 10 2020
accepted: 24 11 2020
pubmed: 20 2 2021
medline: 15 12 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) incidence and related-deaths are increasing worldwide. PDAC is characterized by poor prognosis due to late diagnosis, high metastatic capacity and resistance to therapy. This is partially due to its specific microenvironment, where the stroma is prominent over tumor cells. Besides the oral and gut microbiota, the intratumor microbiome, i.e. the bacterial and fungal microorganisms present within the tumor, was recently introduced as a new partner of the tumor microenvironment of PDAC modulating pancreatic carcinogenesis, intratumor immune infiltrates, and response to chemotherapy. In this review, we propose an overview of current knowledge about the roles of bacteria and fungi in PDAC development and biology, and discuss potential therapeutic implications.

Identifiants

pubmed: 33607375
pii: S2210-7401(20)30355-7
doi: 10.1016/j.clinre.2020.101589
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101589

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Annemilaï Tijeras-Raballand (A)

OncoMEGA, Lamorlaye, France.

Marc Hilmi (M)

OncoMEGA, Lamorlaye, France; Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University (UVQ), Paris Saclay University, Saint-Cloud, France.

Lucile Astorgues-Xerri (L)

OncoMEGA, Lamorlaye, France.

Rémy Nicolle (R)

OncoMEGA, Lamorlaye, France; Carte d'Identité des Tumeurs (Tumors Identity Card), La Ligue Contre le Cancer, Paris, France.

Ivan Bièche (I)

Pharmacogenomic Unit, Genetic Department, Curie Institute, Paris, France.

Cindy Neuzillet (C)

OncoMEGA, Lamorlaye, France; Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University (UVQ), Paris Saclay University, Saint-Cloud, France. Electronic address: cindy.neuzillet@curie.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH